Residual Platelet Activity In Advanced Peripheral Artery Disease
Summary
The peripheral arterial disease (PAD) is a common atherosclerotic disease manifestation and its prevalence increase with age and with the simultaneous presence of cardiovascular risk factors. PAD patients are usually treated, as a first line treatment, with the exercise therapy, combined with the pharmacological antiplatelet therapy. In the case of first line therapy failure, PAD patients usually undergoing to invasive revascularization procedures. After a peripheral stent has been located, the major follow-up problem is the restenosis rate. Published studies describe how, in a large amount of patients, can be recognised an high residual platelet activity. These data about PAD patients at the moment are lacking . The authors would evaluate the incidence of PAD patients with an high residual platelet activity.
Timeline
- Start
- 2012-07
- Primary completion
- 2014-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Aspirin | Small molecule | 100 mg | — |
| Background | Clopidogrel | Small molecule | 75 mg | — |